AR035506A1 - Procedimiento para preparar extractos acuosos de plantas y extractos obtenidos de este modo - Google Patents

Procedimiento para preparar extractos acuosos de plantas y extractos obtenidos de este modo

Info

Publication number
AR035506A1
AR035506A1 ARP010105480A ARP010105480A AR035506A1 AR 035506 A1 AR035506 A1 AR 035506A1 AR P010105480 A ARP010105480 A AR P010105480A AR P010105480 A ARP010105480 A AR P010105480A AR 035506 A1 AR035506 A1 AR 035506A1
Authority
AR
Argentina
Prior art keywords
plants
treatment
plant
aqueous extracts
extracts
Prior art date
Application number
ARP010105480A
Other languages
English (en)
Original Assignee
Bomsund Grupo Asesor Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomsund Grupo Asesor Sl filed Critical Bomsund Grupo Asesor Sl
Publication of AR035506A1 publication Critical patent/AR035506A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

La presente proporciona un procedimiento para preparar extractos acuosos de vegetales, particularmente de plantas y, más en particular, de plantas seleccionadas entre las especies: Mentha sativa, Pimpinella anisum, Eleutherococcus senticosus, Equinacea angustifolia, Symphytum officinalis, Equisetum arvense, Calendula officinalis, Agrimonia eupatoria, Lepidium latifolium y Lamium album. Dicho procedimiento comprende las etapas de: a) descontaminación de la planta, b) trituración de la planta, c) tratamiento de la planta triturada con una radiación láser, d) suspensión de la mezcla obtenida en la etapa c) en agua, e) y f) separación del líquido resultante. La presente también proporciona los extractos acuosos obtenidos mediante el presente procedimiento y dichos extractos acuosos liofilizados, así como preparaciones farmacéuticas que los incluyen para el tratamiento de enfermedades inmunosupresoras tales como cáncer, tuberculosis, gripe, resfriado común y SIDA, o en el tratamiento de enfermedades virales tales como la hepatitis.
ARP010105480A 2000-11-27 2001-11-26 Procedimiento para preparar extractos acuosos de plantas y extractos obtenidos de este modo AR035506A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/001947 WO2002041908A1 (en) 2000-11-27 2000-11-27 Process for preparing aqueous extracts of plants and extracts so obtained

Publications (1)

Publication Number Publication Date
AR035506A1 true AR035506A1 (es) 2004-06-02

Family

ID=11004018

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105480A AR035506A1 (es) 2000-11-27 2001-11-26 Procedimiento para preparar extractos acuosos de plantas y extractos obtenidos de este modo

Country Status (23)

Country Link
US (1) US7402324B1 (es)
EP (1) EP1339420B1 (es)
JP (1) JP2004525866A (es)
KR (1) KR100775153B1 (es)
CN (1) CN1261162C (es)
AR (1) AR035506A1 (es)
AT (1) ATE275960T1 (es)
AU (2) AU2001220195B2 (es)
BR (1) BR0017378A (es)
CA (1) CA2430113A1 (es)
DE (1) DE60013919T2 (es)
DK (1) DK1339420T3 (es)
ES (1) ES2228641T3 (es)
HR (1) HRP20030482A2 (es)
HU (1) HUP0501092A3 (es)
IL (1) IL156165A0 (es)
MX (1) MXPA03004721A (es)
MY (1) MY129109A (es)
NO (1) NO20032369L (es)
NZ (1) NZ526642A (es)
PT (1) PT1339420E (es)
UA (1) UA75624C2 (es)
WO (1) WO2002041908A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237060A1 (en) * 2002-06-29 2004-01-19 Biokorea Co., Ltd (e)-1-(((2e, 4e)-1-hexyl-2,4-octadecadienyl)oxy)-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis
WO2007141661A2 (en) * 2006-02-22 2007-12-13 Tracey Anne Seipel Herbal compositions for the prevention or treatment of benign prostatic hyperplasia
US20080319042A1 (en) * 2007-02-13 2008-12-25 Harry Fong Compositions and methods for treatment of liver disease
KR101124364B1 (ko) * 2009-03-31 2012-03-15 (주)국심 간세포 보호 기능성 국화차 조성물
US20120213870A1 (en) * 2011-02-17 2012-08-23 Maher El-Aaser Composition and method for treating liver disease
US10758581B2 (en) 2013-06-11 2020-09-01 Carmel Haifa University Economic Corporation Ltd. Treatment of cancer
ES2533200B1 (es) * 2013-10-04 2016-01-15 Rafael GALLART GRAU Procedimiento para preparar extractos acuosos de plantas
FR3023482B1 (fr) * 2014-07-11 2016-07-15 Laboratoires Lea Extrait hydroglycerine d'ombellifere pour un usage cosmetique
TR201514423A3 (tr) 2015-11-16 2017-02-21 Bahadir Sueleyman Kanser tedavisi için bir ekstre.
CN112808243A (zh) * 2021-01-07 2021-05-18 广州宝力环保科技有限公司 一种高效去除甲醛空气净化剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733419B1 (fr) * 1995-04-27 1997-08-08 Blackborough Ltd Extraits vegetaux, leur procede de fabrication, conjugues phytoproteiques les contenant et leurs applications
RU2118166C1 (ru) * 1996-12-04 1998-08-27 Государственный научный центр РФ "НИОПИК" Средство для лечения онкологических заболеваний в виде водного экстракта растительного сырья и способ его получения
US6143337A (en) * 1999-04-30 2000-11-07 The United States Of America As Represented By The Secretary Of Agriculture Extraction of pectin by microwave heating under pressure

Also Published As

Publication number Publication date
MY129109A (en) 2007-03-30
CN1479624A (zh) 2004-03-03
JP2004525866A (ja) 2004-08-26
HUP0501092A3 (en) 2008-08-28
NO20032369L (no) 2003-07-25
CA2430113A1 (en) 2002-05-30
ES2228641T3 (es) 2005-04-16
DK1339420T3 (da) 2005-01-17
CN1261162C (zh) 2006-06-28
HUP0501092A2 (en) 2007-12-28
PT1339420E (pt) 2005-01-31
ATE275960T1 (de) 2004-10-15
EP1339420B1 (en) 2004-09-15
DE60013919T2 (de) 2005-09-29
NO20032369D0 (no) 2003-05-26
NZ526642A (en) 2004-11-26
DE60013919D1 (de) 2004-10-21
MXPA03004721A (es) 2005-01-25
BR0017378A (pt) 2004-06-29
KR20030063393A (ko) 2003-07-28
UA75624C2 (en) 2006-05-15
IL156165A0 (en) 2003-12-23
US7402324B1 (en) 2008-07-22
KR100775153B1 (ko) 2007-11-12
WO2002041908A1 (en) 2002-05-30
AU2019501A (en) 2002-06-03
AU2001220195B2 (en) 2005-10-27
HRP20030482A2 (en) 2005-04-30
EP1339420A1 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AR035506A1 (es) Procedimiento para preparar extractos acuosos de plantas y extractos obtenidos de este modo
BR112022011795A2 (pt) Métodos para preparar e isolar uma população terapêutica de linfócitos e para tratar câncer em um indivíduo, população terapêutica de linfócitos, bolsa criopreservada, recipiente flexível, e, sistema para extração de linfócitos
CU24495B1 (es) Compuestos que expanden las células hematopoyéticas y método ex vivo para expandir las células hematopoyéticas
BR112019001923A2 (pt) moduladores de nmda de espiro-lactama e métodos de sua utilização
CL2021001209A1 (es) Constructos de suministro para transcitosis y métodos relacionados
Milan et al. Effects of Polygonum aviculare herbal extract on sperm parameters after EMF exposure in mouse
CO6751233A2 (es) Composiciones bioestimulante de crecimiento y producción de plantas de capsicum chinese i. que comprende una solución de hidratos de carbono proveniente de quitosano y un hidrolizado parcial de saccharomyces cerevisiae; procedimiento de aplicación de dicha composición
Brandão et al. Complementary/alternative medicine in Latin America: use of herbal remedies among a Brazilian metropolitan area population
CO5200850A1 (es) Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion
Ibrahim et al. Preliminary Phytochemical and Pharmacological Screenings of Plumbago indica L. and Alpinia conchigera Griff.
CO6280404A2 (es) Proceso de obtencion de un extracto estandarizado a partir de una planta del genero aleurites, extrcto obtenido y composicion farmaceutica que comprende dicho extracto
HN1998000141A (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientom para fabricarla.
AR018376A1 (es) Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
Grebennikova et al. Biologically active substances of Hyssopus officinalis L.
CO5310569A1 (es) Procedimiento para preparar extractos acuosos de plantas y extractos asi obtenidos de este modo
Yadegari et al. Antifertility effects of Falcaria vulgaris in female rat
Oyewo et al. Evaluation of ethanolic extract of ginger on the histology of the testes and sperm of adult wistar rats
MX348056B (es) Procedimiento para la produccion de extractos secos.
Lins Brandão et al. Complementary/Alternative Medicine in Latin America: Use of Herbal Remedies among a Brazilian Metropolitan Area Population.
Pournarani et al. Educational Program Based on the Health Action Process Approach and Its Effect on Integrated Pest Management Adoption in Greenhouse Farmers
Baudrihaye European vaccine manufacturers: present status and future trends
Tai et al. Endometrial-engineered cell sheets for resumption of fertility
da Silva et al. BioMed Research International
Arnold Prospects of using MS for in-vitro propagation of Chlorophytum borivilianum
Ordaz-Silva et al. Efecto de Hongos Entomopatogenos Sobre Larvas de Mosca Sierra (Monoctenus sanchezi Smith) 1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FC Refusal
FB Suspension of granting procedure